跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BI-1
首页
药物
BI-1
BI-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Cathartic composition
EP 1857105 B1
申请人: SUCAMPO AG
优先权: 2000
CN
EP
US
WO
15 件公开
Bi-specific antibodies against TIM-3 and PD-1 for immunotherapy in chronic immune conditions
US 9163087 B2
申请人: KUCHROO VIJAY K
优先权: 2011
US
5 件公开
BI-SPECIFIC BINDING MOLECULES
US 2021317204 A1
申请人: ALMAC DISCOVERY LTD
优先权: 2017
CN
US
WO
3 件公开
Copper alloy casting and method of casting the same
US 10017841 B2
申请人: OISHI KEIICHIRO
优先权: 2004
CN
US
3 件公开
METHOD FOR THE PURIFICATION OF SUBSTITUTED CYCLOPENT-2-EN-1-ONE CONGENERS AND SUBSTITUTED 1,3-CYCLOPENTADIONE CONGENERS FROM A COMPLEX MIXTURE USING COUNTERCURRENT SEPARATION
US 2011257074 A1
申请人: METAPROTEOMICS LLC
优先权: 2009
CN
US
3 件公开
Anti-angiogenesis fusion protein and uses thereof
US 11518819 B2
申请人: TRICAN BIOTECHNOLOGY CO LTD
优先权: 2018
CN
US
3 件公开
AMINO ACID SEQUENCES TARGETING HUMAN CD4, CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN, BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY
US 2011318347 A1
申请人: BLANCHETOT CHRISTOPHE
优先权: 2009
US
3 件公开
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
US 10160806 B2
申请人: MACROGENICS INC
优先权: 2015
US
3 件公开
Bi-specific annexin A5/IGF-1 proteins and methods of use thereof to promote regeneration and survival of tissue
US 10040840 B2
申请人: SILVER CREEK PHARMACEUTICALS INC
优先权: 2016
US
3 件公开
Thiazol-(bi)cycloalkyl-carboxanilides
US 2006155122 A1
申请人: DUNKEL RALF
优先权: 2002
CN
US
2 件公开
第 1 / 10 页
上一页
下一页
药物
反馈